Riverhead Capital Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $131K | Hold |
11,500
| – | – | ﹤0.01% | 1257 |
|
|
2019
Q2 | $129K | Hold |
11,500
| – | – | ﹤0.01% | 1281 |
|
|
2019
Q1 | $93K | Buy |
11,500
+3,800
| +49% | +$30.7K | ﹤0.01% | 1340 |
|
|
2018
Q4 | $49K | Buy |
7,700
+2,800
| +57% | +$17.8K | ﹤0.01% | 1418 |
|
|
2018
Q3 | $48K | Buy |
4,900
+2,300
| +88% | +$22.5K | ﹤0.01% | 1494 |
|
|
2018
Q2 | $22K | Buy |
+2,600
| New | +$22K | ﹤0.01% | 1510 |
|